Shattuck Labs logo
Shattuck Labs
STTK | NASDAQ
Chart Builder DCF Calculator
$4.66
+$0.01 (+0.22%)
At close: Nov 16, 2026, 4:00 PM ET
$4.66
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Shattuck Labs Company Profile

Company profile explained

Company Profile

Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.

Key Executives

Name Position
Taylor H. Schreiber Co-Founder, Chief Executive Officer & Director
Andrew R. Neill Chief Financial Officer
Abhinav A. Shukla Chief Technical Officer
Arundathy Nirmalini Pandite Chief Medical Officer
Brad Huckabee Vice President of Accounting & SEC reporting
Casi DeYoung Chief Business Officer
Kelli Collin Senior Vice President of Quality
Stephen Stout General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
Suresh de Silva Chief Scientific Officer
Thomas Lampkin Senior Vice President of Regulatory Affairs

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 11, 2026 S-8 Filing
Aug 11, 2026 8-K Current Report
Aug 11, 2026 10-Q Quarterly Report
Jul 17, 2026 SC 13D/A [Amend] Filing
Jul 07, 2026 4 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 144 Filing
View All SEC Filings ➞
Shattuck Labs
Shattuck Labs logo
Country United States
IPO Date Oct 9, 2020
Industry Biotechnology
Sector Healthcare
Employees 40
CEO Taylor H. Schreiber

Contact Details

500 West 5th Street Austin, Texas 78701 United States

Stock Details

Ticker Symbol STTK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001680367
CUSIP Number 82024L103
ISIN Number US82024L1035
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.